HTA23 Reasons for a Negative Pharmaceutical Benefits Advisory Committee (PBAC) Review in Rare Diseases in Australia: A Comprehensive Analysis
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1708
https://www.valueinhealthjournal.com/article/S1098-3015(23)04838-6/fulltext
Title :
HTA23 Reasons for a Negative Pharmaceutical Benefits Advisory Committee (PBAC) Review in Rare Diseases in Australia: A Comprehensive Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04838-6&doi=10.1016/j.jval.2023.09.1708
First page :
Section Title :
Open access? :
No
Section Order :
11152